Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2007
10/23/2007US7285389 Protein, gene encoding the same, and method of utilization thereof
10/23/2007US7285383 Cell with recombinant nucleic acid comprisinga hepatitis C virus internal ribosome etry site (IRES) operably linked to a polynucleotide encoding a reporter protein; and a test compound; drug screening for viricides; determining if translation is allowed or prevented by interaction with drug or cell
10/23/2007US7285382 Compositions and methods for treatment of cancer
10/23/2007US7285381 Insertion in amino acid sequence of structural protein; purification, mutagenesis, genetic engineering; higher titers; gene therapy, cell transformation
10/23/2007US7285379 Complex of albumin and porphyrin; mixing under inert gas albumin and porphyrin
10/23/2007US7285291 Such as cows or sheep having leucosis, substance is obtained from the lipid-free blood plasma fraction of a pregnant animal
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285281 Genetically engineered toxin comprising a-subunit of wildtype cholera toxin for treatment and prevention of infections, cell proliferative, nervous system and metabolic disorders
10/23/2007US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007US7285278 Method and device for detecting feline immunodeficiency virus
10/23/2007US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007US7285275 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
10/23/2007US7285274 Baculovirus produced Plasmodium falciparum vaccine
10/23/2007US7285272 Method and device for detecting feline immunodeficiency virus
10/23/2007US7285267 Antiinflammatory agents
10/23/2007CA2341946C Polypetides and compositions prepared from the amplification of the hiv-2 and siv-type retrovirus genome,
10/23/2007CA2272130C Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
10/23/2007CA2263889C P-selectin ligand proteins
10/23/2007CA2216250C Casein phosphopeptide, casein containing same and process for the preparation thereof
10/23/2007CA2191612C A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same
10/23/2007CA2155630C Low temperature albumin fractionation using sodium caprylate as a partitioning agent
10/23/2007CA2111325C Detection of mammalian immunodeficiency viruses
10/23/2007CA2086258C Pasteurella multocida toxoid vaccines
10/18/2007WO2007118051A2 Lipid therapy
10/18/2007WO2007117564A2 Clay-binding peptides and methods of use
10/18/2007WO2007117467A2 Use of tm-601 for the diagnosis and treatment of tumors
10/18/2007WO2007117215A1 Binder for c-reactive protein
10/18/2007WO2007116958A1 Grh5 GENE CAPABLE OF IMPARTING INSECT RESISTANCE TO RICE PLANT AND USE THEREOF
10/18/2007WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007WO2007116597A1 Tumor marker, diagnostic kit for tumor, method for determination of tumor marker, and diagnostic method for tumor
10/18/2007WO2007116316A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
10/18/2007WO2007116278A2 Antiangiogenic peptide and therapeutic uses thereof
10/18/2007WO2007115953A1 Covalent factor vii-tissue factor complex
10/18/2007WO2007115797A2 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity
10/18/2007WO2007115726A2 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity
10/18/2007WO2007115578A1 Synthetic mecp2 sequence for protein substitution therapy
10/18/2007WO2007115571A2 Erbb receptor-derived peptide fragments
10/18/2007WO2007115414A1 Modified h2 relaxin for tumor suppression
10/18/2007WO2007115364A1 Transcription factor modulator
10/18/2007WO2007098951A3 Method and apparatus for extraction of protein material from silkworm glands
10/18/2007WO2007094926A3 Rage fusion proteins and methods of use
10/18/2007WO2007085923A3 Novel fluorescent proteins and methods for using same
10/18/2007WO2007083246A3 Vegf variants
10/18/2007WO2007077464A3 Chicken virus vaccine and diagnostic
10/18/2007WO2007059715A3 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
10/18/2007WO2007054600B1 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination
10/18/2007WO2007045243A3 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1
10/18/2007WO2007034166A8 Adjuvanted vaccine
10/18/2007WO2007011265A8 Method for blocking noggin2 target specific activities
10/18/2007WO2002061054A3 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel
10/18/2007WO2002010354A3 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2)
10/18/2007WO2002010198A3 Polynucleotides and polypeptides
10/18/2007WO2001030974A3 Molecules targeting cd40 which do not activate cd40-expressing cells
10/18/2007WO2000071671A3 New mutant genes in familial british dementia and familial danish dementia
10/18/2007US20070245433 Transgenic plant with a plant transformation vector comprising a nucleotide sequence encoding a HIO32.3 polypeptide; a high oil content phenotype
10/18/2007US20070245428 Bacillus thuringiensis cry gene and protein
10/18/2007US20070245427 Pesticidal polypeptide for protecting plants against insects
10/18/2007US20070244304 Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof
10/18/2007US20070244301 Pegylated factor VIII
10/18/2007US20070244299 Method of Stabilizing Proteins
10/18/2007US20070244298 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed
10/18/2007US20070244297 Human calcium channel compositions and methods
10/18/2007US20070244064 Methods and compositions to induce antitumor response
10/18/2007US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt
10/18/2007US20070244054 Peptides for use in treating obesity
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007US20070244050 Peptides as solubilizing excipients for transforming growth factor beta proteins
10/18/2007US20070244048 Neuromedin U receptor agonists and uses thereof
10/18/2007US20070244047 Albumin fusion proteins
10/18/2007US20070244044 Antimicrobial Peptides
10/18/2007US20070244043 Recombinant E-selectin made in insect cells
10/18/2007US20070244042 Anti-cancer agents and/or transforming growth factor beta (TGF-beta or TGF beta ) antagonists; comprising a therapeutically effective amount of soluble type II receptor (sRII) and a soluble type III receptor (sRIII)
10/18/2007US20070244041 Peptide Yy Analogues
10/18/2007US20070244040 polypeptides and carriers, used for inducing and/or enhancing apoptosis, as well as for the treatment of cancer
10/18/2007US20070244037 Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation
10/18/2007US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same
10/18/2007US20070244033 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein
10/18/2007US20070244032 Cancer Cell Targeting Gene Delivery Method
10/18/2007US20070244021 Polypeptides with perhydrolase activity
10/18/2007US20070243629 High Affinity Ligands for Influenza Virus and Methods for Their Production
10/18/2007US20070243611 WT1 interacting protein WTIP
10/18/2007US20070243606 Ribonucleases and methods of them recombinantly
10/18/2007US20070243605 Ribonucleases and methods of making them recombinantly
10/18/2007US20070243594 Oxidoreductase from Pichia Capsulata
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007US20070243587 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
10/18/2007US20070243586 Novel organic anion transport proteins
10/18/2007US20070243585 Using expression vector comprising bacterial nucleotide sequences to prepare polypeptides for use in diagnosis, prevention and treatment of microorganismal infection
10/18/2007US20070243584 Tetramerizing polypeptides and methods of use
10/18/2007US20070243580 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/18/2007US20070243579 Selection Markers Useful for Heterologous Protein Expression
10/18/2007US20070243577 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms
10/18/2007US20070243569 producing a kinase/phosphatase inducible domain by replacing a structurally significant glutamic acid or aspartic acid residue in an EF hand domain with a replacement serine or threonine residue; producing a phosphorylation-dependent protein domain; Alzheimer's and heart disease
10/18/2007US20070243562 Lectins for Analyzing Sugar Chains and Method of Using the Same
10/18/2007US20070243558 Peptide Stabilization
10/18/2007US20070243555 Method of Detecting the Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) at Cell Exterior
10/18/2007US20070243554 Carbon nanotube binding peptides
10/18/2007US20070243526 AAV capsid library and AAV capsid proteins
10/18/2007US20070243524 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
1 ... 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 ... 2916